FDAnews
www.fdanews.com/articles/131447-astrazeneca-net-falls-27-percent-on-generic-competition

AstraZeneca Net Falls 27 Percent on Generic Competition

October 28, 2010
AstraZeneca Plc fell the most in almost nine months in London trading after saying fourth-quarter comparisons would be “demanding” as generic competition cuts into profit.
Bloomberg